Skip to main content
. Author manuscript; available in PMC: 2022 Jun 8.
Published in final edited form as: Cancer Res. 2020 Nov 11;81(3):763–775. doi: 10.1158/0008-5472.CAN-20-2674

Figure 2. CND-Dox-TF synthesis and validation.

Figure 2.

A) Schematic of CND-Dox-TF synthesis. B) Chemical structure of CND-Dox-TF conjugate showing carbodiimide bonds to Dox and holo-TF. C) Normalized photoluminescence emission spectra of CND-Dox-TF excited at specific excitation wavelengths related to each single component (TF-280, CNDs-330–370, Dox-480 nm) which confirms the presence of each individual component in the nanocarrier conjugate.